How big is the MEA Biomedical Sensors Market?

The MEA Biomedical Sensors Market size is expected to reach USD 0.28 billion in 2024 and grow at a CAGR of 6.90% to reach USD 0.41 billion by 2029. Read More

What is the current MEA Biomedical Sensors Market size?

In 2024, the MEA Biomedical Sensors Market size is expected to reach USD 0.28 billion. Read More

Who are the key players in MEA Biomedical Sensors Market?

NXP Semiconductors, GE HealthCare Technologies, Inc., Honeywell International Inc., Analog Devices Inc. and Medtronic are the major companies operating in the MEA Biomedical Sensors Market. Read More

What years does this MEA Biomedical Sensors Market cover, and what was the market size in 2023?

In 2023, the MEA Biomedical Sensors Market size was estimated at USD 0.26 billion. The report covers the MEA Biomedical Sensors Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the MEA Biomedical Sensors Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

MEA Biomedical Sensors Market Size & Share Analysis - Industry Research Report

Middle East and Africa Biomedical Sensors Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Middle East and Africa Biomedical Sensors Market Report is Segmented by Type (Wired and Wireless), Sensor Type (Temperature, Pressure, Image Sensor, Biochemical, Inertial Sensor, Motion Sensor, and Electrocardiogram), Industry (Pharmaceutical and Healthcare), and Country (Saudi Arabia, South Africa, and United Arab Emirates). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

MEA Biomedical Sensors Industry Overview

The Middle East and Africa biomedical sensors market is highly fragmented due to the presence of both global players and small and medium-sized enterprises. Some of the major players in the market are NXP Semiconductors, GE HealthCare Technologies, Inc., Honeywell International Inc., Analog Devices, Inc., and Medtronic. Players in the market are adopting strategies such as partnerships and acquisitions to enhance their product offerings and gain sustainable competitive advantage.

In October 2023, the Ministry of Investment Saudi Arabia signed eight MoUs, valued at USD 1.07 billion, with seven international and local companies. These agreements will lead to the localization of the supply chain for advanced medical devices, encompassing stents, sutures, and sensors.
In August 2023, GE HealthCare announced that the FDA cleared its Portrait VSM vital signs monitor, which allows hospitals to continuously monitor critical signs and enable patients to walk around their wards. Wireless sensors that the patients wear are combined with a smartphone-style monitor in the Portrait device.